Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Teva
Moodys
US Department of Justice
Fuji
Citi
Farmers Insurance
Mallinckrodt
Deloitte

Generated: October 24, 2017

DrugPatentWatch Database Preview

DEPO-PROVERA Drug Profile

« Back to Dashboard

What is the patent landscape for Depo-provera, and when can generic versions of Depo-provera launch?

Depo-provera is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in DEPO-PROVERA is medroxyprogesterone acetate. There are nineteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.

Summary for Tradename: DEPO-PROVERA

US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list5
Bulk Api Vendors: see list40
Clinical Trials: see list55
Patent Applications: see list5,395
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEPO-PROVERA at DailyMed

Pharmacology for Tradename: DEPO-PROVERA

Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
DEPO-PROVERA
medroxyprogesterone acetate
INJECTABLE;INJECTION012541-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DEPO-PROVERA
medroxyprogesterone acetate
INJECTABLE;INJECTION012541-003Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DEPO-PROVERA
medroxyprogesterone acetate
INJECTABLE;INJECTION020246-001Oct 29, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DEPO-PROVERA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
DEPO-PROVERA
medroxyprogesterone acetate
INJECTABLE;INJECTION012541-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pharmacia And Upjohn
DEPO-PROVERA
medroxyprogesterone acetate
INJECTABLE;INJECTION012541-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Federal Trade Commission
Daiichi Sankyo
Accenture
Fuji
AstraZeneca
Cantor Fitzgerald
QuintilesIMS
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot